HYD
HYDRIX FPO [HYD]
Technology · ASX Small Cap
$0.0040 +0.0%
Updated 14 Jul 2026 · Signals refresh every scan
Get alerts when HYD triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Bollinger Bands are tightening — volatility is coiling up for a potential breakout
- Watch out — volume is flowing out even as price holds up. Distribution pattern
- Knocking on the door of resistance — if it punches through, things could get interesting
- Volume-price trend suggests distribution — sellers may be sneaking out while price holds
- Low cash runway (2 quarters) - dilution risk
- Low P/S ratio (0.6x)
- Near 52-week low (3% of range)
- Micro-cap ($5-20M) - high risk
- New substantial holder(s) (1)
- Substantial holder(s) ceased (1)
- CANSLIM S: Tight float (16%)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 71% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (5.22%/day)
- Altman Z-Score distress zone (0.42 < 1.81, low-confidence approx)
- Penny stock risk ($0.004)
- Beneish M-Score -2.12 (grey zone -2.22 to -1.78): possible earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Stochastic is stretched into overbought — could need a breather
- Below the 200-day average — the long-term trend is still working against it
- Revenue declining (-14%)
- Piotroski F-Score weak (1/9, low-confidence approx)
- Deeply negative margins (-57%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -14% — the top line is shrinking
Ask Scout AI about HYD
3 free messages/day · Unlimited with Pro
Recent Catalysts
HIGH Becoming a substantial holder
HIGH Ceasing to be a substantial holder
NONE Hydrix engaged to advance next-gen stroke therapy platform
NONE Application for quotation of securities - HYD
NONE Notification of cessation of securities - HYD
Recent ASX Announcements
| 2026-06-24 | Becoming a substantial holder |
| 2026-06-23 | Hydrix engaged to advance next-gen stroke therapy platform |
| 2026-06-22 | Application for quotation of securities - HYD |
| 2026-06-22 | Notification of cessation of securities - HYD |
| 2026-06-19 | Ceasing to be a substantial holder |
Key Metrics
$5.8M
Market Cap
2.2M
Avg Volume
0.8x
Vol Ratio
$0.00 — $0.04
52-Week Range
N/A
Short Interest
N/A
Cash Runway
N/A
ROE
-57.4%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 16% |
| L | Leader vs Laggard | laggard | RS: -41 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Technology
93 tickers in this sector
View all Technology signals →Track HYD and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required